Background {#Sec1}
==========

Varicella-zoster virus (VZV) is a neurotrophic alphaherpesvirus infecting exclusively humans. VZV causes varicella (chickenpox) during the first infection (usually in childhood) and then becomes latent in cranial-nerve and dorsal-root ganglia. It can reactivate after several years causing zoster (shingles), sometimes followed by post-herpetic neuralgia. Reactivation generally occurs in elder population or in immunocompromised patients \[[@CR1]\]. VZV can cause a wide spectrum of central nervous system (CNS) manifestations during first infection or later if reactivation occurs, such as encephalitis, cerebellitis, meningitis, vasculitis, stroke, polyneuropathy. The involvement of CNS can occur without concomitant skin eruption (zoster sine herpete) \[[@CR2]\]. This scenario is uncommon both in children and in immunocompetent patients \[[@CR3]\]. In this report, we describe a case of encephalitis due to VZV reactivation without the expression of vesicular rash in a 12-year-old immunocompetent girl.

Case presentation {#Sec2}
=================

A 12-year-old girl was admitted to our hospital for persisting headache, started six days before. At the admission she presented also cough and rhinitis; she referred mild fever (axillary temperature 38 °C) during the previous days and three episodes of vomit. If at the beginning the pain was controlled by paracetamol, during the last days the headache had become deep, localized in the frontal region and associated to photophobia, even though at the beginning the pain was controlled by paracetamol. She had no personal or familial history of headache. Her medical history was unremarkable except for an episode of chickenpox during her infancy. On physical examination vital signs were stable (heart rate 90 bpm, blood pressure 111/73 mmHg, temperature 38 °C, GCS 15), the girl appeared suffering but her general conditions were good. Central nervous system examination didn't show any neurological deficit, Kernings and Brudzinski signs were negative, she had no neck stiffness. Deep tendons reflexes were normal. Pupils were equal, round and reactive to light; accommodation reflex was present. Nor nystagmus or diplopia was noticed. Clinical examination of heart, lungs and abdomen was negative. On the skin no lesions were present. Blood count was in normal range, reactive C-protein (CRP) and procalcitonin (PCT) were negative, liver and renal functions were preserved. Analgesic and antipyretic treatment was administered. Nasal endoscopy was performed on the second day of hospitalization and highlighted a picture of acute bacterial sinusitis. Antibiotic therapy was started. The day after the girl developed altered mental status and psychomotor agitation; the headache worsened and was accompanied by three episodes of vomiting events; in few hours the girl developed drowsiness and became less responsive to stimuli. Blood tests were repeated but values were still in normal range. Computed tomography (CT) was performed immediately but was unremarkable. Electroencephalogram (EEG) showed "severe alteration of cortical electrogenesis with exacerbation of diffuse slow cortical activity, with fronto-temporal predominance". Cerebrospinal fluid examination showed increased protein concentration (72 mg/dl), normal glucose concentration (52 mg/dl; blood glucose 105 mg/dl), lymphocytic pleocytosis (484 white cells/µL, 79% lymphocytes, 20% monocytes). The findings were suggestive for viral infection of CNS. Varicella-zoster virus was detected using polymerase chain reaction (PCR). The research of genome of herpes simplex virus 1 and 2, human herpes virus 6, cytomegalovirus and Ebstein-Barr virus was negative. Serological tests showed the presence of IgG vs. VZV and absence of IgM vs. VZV, confirming the reactivation of VZV. Immunological screening for HIV was negative, serum immunoglobulins, T and B lymphocytes counts, complement proteins levels were within normal range for age.

The girl was treated with intravenous acyclovir 10 mg/kg three times a day. During the first day of antiviral therapy her clinical conditions rapidly improved and the following day she was well oriented, smiling and quiet, not remembering the events of the days before. Her headache disappeared completely after two days. After 2 weeks of treatment, she was dismissed with oral acyclovir to be continued for 2 weeks more.

EEG was performed again after 3 and 12 days from the onset of encephalitis, showing progressive improvement of cortical activity, but a persistent slow focal activity in the right temporal region was registered. Magnetic resonance was performed after 2 days from the diagnosis of encephalitis and one month after the discharge and was unremarkable in both cases. Lumbar puncture was performed again after 14 days of therapy: protein concentration and glucose level were in normal range, a mild leukocytosis was still present (40 white cells/µL, with 93% of lymphocytes). PCR for VZV at that time was negative.

Discussion and Conclusions {#Sec3}
==========================

Varicella-zoster virus (VZV) causes two clinically distinct diseases. Varicella (or chickenpox) is the result of primary infection, it is extremely contagious and occurs mainly among preschool and school-aged children; the main characteristic is a generalized itchy vesicular rash. Although in most cases the evolution of varicella is benign, complications and atypical presentations can occur in previously healthy people, but their incidence is greater in immunocompromised patients \[[@CR4]\]. After primary infection of varicella or after vaccination, VZV remains latent in the sensory ganglion cells and can reactivate if cell-mediated immunity declines as a consequence of aging of the patient or for the onset of an immunosuppressive state. Therefore, reactivation of VZV is rare in children \[[@CR5]\].

It is known that varicella-zoster virus can cause several CNS disorders, such as meningitis, cerebellitis, myelitis, vasculitis and stroke-related syndromes. It was recognized as the second most common virus causing viral encephalitis, after herpes simplex virus. This frequency is declining in recent years in some countries after the introduction of VZV vaccination. VZV infections of the central nervous system are generally more frequent in immunocompromised individuals, but are not exclusive of this group of patients. In children, the most common CNS complication is cerebellitis that can develop during primary infection. In adults, encephalitis and meningitis have a higher incidence than in children and are usually subsequent to the reactivation of VZV \[[@CR2]\]. In pediatric age encephalopathy develops almost exclusively after chickenpox and is related to Reye's syndrome or to a process of perivenous inflammation and demyelination \[[@CR1]\]. Neurological vascular complications are described both in adults and children \[[@CR6]\]. Besides, pseudotumor cerebri has also been described as a rare neurological complication of VZV reactivation in pediatric age \[[@CR7]\]. The reactivation of VZV in immunocompetent patients is uncommon, namely in childhood. Most of cases described in literature involve adults, both for encephalitis \[[@CR8]\] and meningitis, more often associated with vesicular rash \[[@CR9], [@CR10]\].

The absence of vesicular rash preceding or following CNS involvement is rare. In a study of CNS complications of VZV carried in 84 children with neurological symptoms associated with VZV infection, only two patients had no rash, despite the diagnosis of VZV meningitis, confirmed by PCR analysis of the CFS \[[@CR3]\].

The case we described presents peculiar medical features: encephalitis was caused by reactivation of VZV in an immunocompetent child, who did not present the typical rash. Consequently, we decided to perform a systematic review of the literature on PubMed database matching words "encephalitis", "central nervous system", "immunocompetent", and "varicella zoster". Of 103 results obtained, we analyzed title and abstract of all relevant papers, regardless of language. We found only two reported cases of encephalitis due to VZV reactivation in pediatric patients in absence of waning of immune system function. A comparison between our case and previous described ones is showed in Table [1](#Tab1){ref-type="table"} \[[@CR11], [@CR12]\]. Patient described by Chiappini et al. had a younger age and the authors presume that early primary infection by VZV could be a risk factor for subsequent reactivation and CNS manifestations. The case we described and the case reported by Spiegel et al. do not support this hypothesis. From the analysis of mentioned cases, previous VZV reactivations do not seem to represent a risk factor. According to the cerebrospinal fluid findings, in our patient and in Spiegel et al. patient the involvement of meninges support the diagnosis of meningoencephalitis. EEG was abnormal in all the three patients, proving the involvement of cerebral parenchyma; neuroimaging in our patient was unremarkable. Even if meningitis due to VZV is more common after a primary infection, some cases of meningitis due to VZV reactivation in immunocompetent children have been reported, mainly (but not exclusively) associated to the presence of vesicular rash \[[@CR13]--[@CR15]\]. In all these cases any involvement of cerebral parenchyma was demonstrated and this supports one of unique feature of our case. To our knowledge, some cases of CNS infection due to reactivation of VZV in vaccinated children have been reported, but genotyping verification of the vaccine strain was available in a relatively small number of patients \[[@CR16]--[@CR18]\]. Regardless our patient, as the other two showed in the table, presented varicella during their infancy and they did not get vaccination.

In our opinion, it is significant to highlight that none of the three patients discussed showed the vesicular rash, therefore we should keep a high level of suspicion of VZV infection of central nervous system even in the absence of suggestive diagnostic clinical features.

In the suspicion of VZV encephalitis, polymerase chain reaction (PCR) allows the detection of viral DNA and RNA in CSF samples with high sensitivity and specificity \[[@CR19], [@CR20]\]. Because virus isolation and detection of intrathecal antibody production usually need at least 10 days after the onset of symptoms to be achieved, PCR is the best technique to make a prompt diagnosis and to start the correct treatment. Moreover herpesvirus isolation from early CSF is exceptional \[[@CR21]\]. In our patient, positive serum IgG and negative IgM allow to distinguish a primary infection from reactivation.

Intravenous acyclovir 10--15 mg/kg every 8 h is the treatment of choice; the recommended duration is 14 days but if compromised immune system function is suspected or known, the treatment should be extended to 21 days. Many experts recommend adjunct corticosteroids if CNS vasculitis is present \[[@CR22]\].

Even if rare, reactivation of VZV with subsequent involvement of central nervous system can occur in previous healthy people, including children. Vesicular rash could be absent; therefore high level of suspicion for VZV infection has to be kept in patients with clinical, biochemical and instrumental findings suggestive for viral meningoencephalitis. PCR of cerebrospinal fluid is the faster tool to achieve a correct diagnosis and start a prompt therapy. Intravenous acyclovir is the drug of choice. Table 1Reported cases of encephalitis caused by varicella zoster virus reactivation in immunocompetent childrenChiappini et al., 2002 \[[@CR11]\]Spiegel et al., 2010 \[[@CR12]\]Our patient, 2020Age and gender2-year-old boy14-year-old girl12-year-old girlChickenpox/vaccination (age)Chickenpox (4 months)Chickenpox (4 years)Chickenpox (NA)Previous reactivationNoZoster (10 years)NoClinical presentation:-FeverYes (T 38.5 °C)Yes (T 39.2 °C)Yes (T 38 °C)-Neurological symptoms & signsFrontal headache, vomiting, disturbed consciousness, miotic pupils, tendon reflexes absent, left ankle clonus, bilateral Babinski's reflexes elicitedParesthesias and hyperesthesia at left limbs, proximal left leg weakness; severe frontal and occipital headache, stiff neck, positive Brudjinski signSevere frontal headache, vomiting,photophobia, altered mental status, psychomotor agitation.- Skin rashNoNoNoCSF:- white cells/mLNormal434484- protein (mg/dL)Normal5972- glucose (mg/dL)Normal4952- PCR for VZV-DNAPositivePositivePositiveIgG and IgM VZVSerum: IgG +, IgM -CSF: IgG and IgM -Serum: IgG +, IgM -Serum: IgG +, IgM -EEGFindings compatible with viral encephalitisRight-hand sided slow waves, compatible with righthemisphere encephalopathySevere alteration of cortical electrogenesis with exacerbation of diffuse slow cortical activity, with fronto-temporal predominanceMRIBilateral multifocal changes in white and gray matter, predominantly on thefronto--parietal cortex4 hyperintense lesions without enhancement after gadolinium injection: 1 in right thalamus, 1 in right temporal subcortical region, 2 in right parietal subcortical regionUnremarkableImmunological screeningHIV Ab negative; IgG, IgA, IgM serum levels, B and T-lymphocyte counts, NK cell subset counts, in vitro T-lymphocyte response to mitogens,MHC I and II class molecule-positive cell counts: normal.HIV Ab negative; IgG, IgA, IgM serum levels, complement studies, total counts and functional studiesof T cells: normal.HIV Ab negative; IgG, IgA, IgM serum levels, B and T-lymphocyte countsTreatment (days)Acyclovir iv (15 days); ceftriaxone iv (5 days)Acyclovir iv (14 days); methylprednisolone iv (5 days)Acyclovir iv (14 days) followed by oral acyclovir (14 days)SequelaeMild right hemiparesisLeft thigh neuralgiaNo
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